Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.4
-295.33%
40%
—
-82.88%
40%
—
5 Years
Score2.4
Net Growth-295.33%
Net Trend40%
Net Income Consistency—
Rev Growth-82.88%
Rev Trend40%
Revenue Consistency—
ATAI Life Sciences BV fundamental performance
Between 2021 and 2025, revenue declined from $ 20M to $ 4M and net income went from -$ 167M to -$ 660M. Revenue increased in 40% of the years measured; net income in 40%.
ATAI Life Sciences BV currently holds a 5-year HDB Score of 2.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 7.23 | — |
1 Year2025-08-12 | $ 4.13 | 75.06% |
5 Years2021-08-12 | $ 14.10 | -48.72% |
All Time2021-06-18 | $ 19.45 | -62.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-06-18 |
|---|---|---|---|---|
| Price | $ 7.23 | $ 4.13 | $ 14.10 | $ 19.45 |
| Return | — | 75.06% | -48.72% | -62.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3M | -$ 663M | $ 230M |
| 2025 | $ 4M | -$ 660M | $ 256M |
| 2024 | $ 308K | -$ 149M | $ 62M |
| 2023 | $ 314K | -$ 40M | $ 179M |
| 2022 | $ 233K | -$ 152M | $ 273M |
| IPO2021 | $ 20M | -$ 167M | $ 362M |
Explore beyond ATAI
You're looking at ATAI Life Sciences BV. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
